NF-κB p65 and p105 implicate in interleukin 1β-mediated COX-2 expression in melanoma cells
NF-κB p65 and p105 implicate in interleukin 1β-mediated COX-2 expression in melanoma cells
复制标题
DOI:
10.1371/journal.pone.0208955
复制
发表时间:
2018-12-18
期刊:
影响因子:
3.7
通讯作者:
Sugiya, Hiroshi
中科院分区:
文献类型:
--
作者:
Kitanaka, Nanako;Nakano, Rei;Sugiya, Hiroshi
Inflammatory and microenvironmental factors produced by cancer cells are thought to directly or indirectly promote cancer cell growth. Prostaglandins, including prostaglandin E2, have key roles as a microenvironment factor in influencing the development of tumors, and are produced by the rate limiting enzyme cyclooxygenase 2 (COX-2). In this study, we used canine melanoma cells treated with the proinflammatory cytokine interleukin 1 beta (IL-1 beta) and investigated the transcriptional factor nuclear factor-kappa B (NF-kappa B) signaling in IL-1 beta-induced COX-2 expression. IL-1 beta induced prostaglandin E2 release and COX-2 mRNA expression in a time- and dose-dependent manner. In the cells treated with the NF-kappa B inhibitors BAY11-7082 and TPC-1, IL-1 beta-mediated prostaglandin E2 release and COX-2 mRNA expression were inhibited. IL-1 beta also provoked phosphorylation of p65/RelA and p105/NF-kappa B1, which are members of the NF-kappa B families. The IL-1 beta-induced phosphorylation of p65 and p105 was attenuated in the presence of both NF-kappa B inhibitors. In melanoma cells transfected with siRNA of p65 or p105, IL-1 beta-mediated COX-2 mRNA expression was inhibited. These findings suggest that canonical activation of NF-kappa B signaling plays a crucial role for inflammatory states in melanoma cells.